Cargando…

Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms

The CRISPR-Cas system of prokaryotic adaptive immunity displays features of a mechanism for directional, Lamarckian evolution. Indeed, this system modifies a specific locus in a bacterial or archaeal genome by inserting a piece of foreign DNA into a CRISPR array which results in acquired, heritable...

Descripción completa

Detalles Bibliográficos
Autores principales: Koonin, Eugene V., Wolf, Yuri I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765028/
https://www.ncbi.nlm.nih.gov/pubmed/26912144
http://dx.doi.org/10.1186/s13062-016-0111-z
_version_ 1782417485911293952
author Koonin, Eugene V.
Wolf, Yuri I.
author_facet Koonin, Eugene V.
Wolf, Yuri I.
author_sort Koonin, Eugene V.
collection PubMed
description The CRISPR-Cas system of prokaryotic adaptive immunity displays features of a mechanism for directional, Lamarckian evolution. Indeed, this system modifies a specific locus in a bacterial or archaeal genome by inserting a piece of foreign DNA into a CRISPR array which results in acquired, heritable resistance to the cognate selfish element. A key element of the Lamarckian scheme is the specificity and directionality of the mutational process whereby an environmental cue causes only mutations that provide specific adaptations to the original challenge. In the case of adaptive immunity, the specificity of mutations is equivalent to self-nonself discrimination. Recent studies on the CRISPR mechanism have shown that the levels of discrimination can substantially differ such that in some CRISPR-Cas variants incorporation of DNA is random whereas discrimination occurs by selection of cells that carry cognate inserts. In other systems, a higher level of specificity appears to be achieved via specialized mechanisms. These findings emphasize the continuity between random and directed mutations and the critical importance of evolved mechanisms that govern the mutational process. Reviewers: This article has been reviewed by Yitzhak Pilpel, Martijn Huynen, and Bojan Zagrovic.
format Online
Article
Text
id pubmed-4765028
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47650282016-02-25 Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms Koonin, Eugene V. Wolf, Yuri I. Biol Direct Opinion The CRISPR-Cas system of prokaryotic adaptive immunity displays features of a mechanism for directional, Lamarckian evolution. Indeed, this system modifies a specific locus in a bacterial or archaeal genome by inserting a piece of foreign DNA into a CRISPR array which results in acquired, heritable resistance to the cognate selfish element. A key element of the Lamarckian scheme is the specificity and directionality of the mutational process whereby an environmental cue causes only mutations that provide specific adaptations to the original challenge. In the case of adaptive immunity, the specificity of mutations is equivalent to self-nonself discrimination. Recent studies on the CRISPR mechanism have shown that the levels of discrimination can substantially differ such that in some CRISPR-Cas variants incorporation of DNA is random whereas discrimination occurs by selection of cells that carry cognate inserts. In other systems, a higher level of specificity appears to be achieved via specialized mechanisms. These findings emphasize the continuity between random and directed mutations and the critical importance of evolved mechanisms that govern the mutational process. Reviewers: This article has been reviewed by Yitzhak Pilpel, Martijn Huynen, and Bojan Zagrovic. BioMed Central 2016-02-24 /pmc/articles/PMC4765028/ /pubmed/26912144 http://dx.doi.org/10.1186/s13062-016-0111-z Text en © Koonin and Wolf. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Opinion
Koonin, Eugene V.
Wolf, Yuri I.
Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms
title Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms
title_full Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms
title_fullStr Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms
title_full_unstemmed Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms
title_short Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms
title_sort just how lamarckian is crispr-cas immunity: the continuum of evolvability mechanisms
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765028/
https://www.ncbi.nlm.nih.gov/pubmed/26912144
http://dx.doi.org/10.1186/s13062-016-0111-z
work_keys_str_mv AT koonineugenev justhowlamarckianiscrisprcasimmunitythecontinuumofevolvabilitymechanisms
AT wolfyurii justhowlamarckianiscrisprcasimmunitythecontinuumofevolvabilitymechanisms